Cargando…

Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves’ Disease

We present a 50-year-old female who was evaluated for the symptoms of thyrotoxicosis. She had low thyroid stimulating hormone (TSH) 0.02 with normal free thyroxine (FT4) 1.00 (0.61-1.76 ng/dL) and normal total triiodothyronine (TT3) 1.0 (0.60-2.20 ng/mL) levels. Her thyrotropin receptor antibody (TR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rehman, Anis, Obici, Silvana, Yaqub, Abid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370676/ https://www.ncbi.nlm.nih.gov/pubmed/32699683 http://dx.doi.org/10.7759/cureus.8683

Ejemplares similares

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

COVID-19-Induced Graves’ Disease
por: Ghareebian, Hagop, et al.
Publicado: (2022)

Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan
por: Alvi, Asim Munir, et al.
Publicado: (2022)

Graves disease following radioiodine therapy for toxic adenoma: Clinical case report
por: Shen, Guohua, et al.
Publicado: (2017)

A Case of Thrombotic Thrombocytopenic Purpura Possibly Induced by Graves’ Disease
por: Bains, Shifali, et al.
Publicado: (2022)

Treatment of Graves' Disease Associated With Severe Neutropenia
por: Laidi, Soukaina, et al.
Publicado: (2022)

Graves' Disease Following COVID-19 Vaccination
por: Singh, Gurdeep, et al.
Publicado: (2022)

Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report
por: AlShehri, Sara, et al.
Publicado: (2022)

A Rare Case of Pembrolizumab-Associated Graves’ Disease
por: Alqaisi, Sura, et al.
Publicado: (2023)

Weathering the Storm: Thyroid Storm Precipitated by Radioiodine Contrast in Metastatic Thyroid Carcinoma
por: Basida, Brinda, et al.
Publicado: (2021)

Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave’s Disease
por: Sawhney, Rahul, et al.
Publicado: (2019)

Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
por: Rayan, Melanie N, et al.
Publicado: (2022)

Granulomatosis With Polyangiitis in Untreated Graves’ Disease: A Rare Event
por: Moosa, Syed Ahmad, et al.
Publicado: (2022)

Antithyroid Drugs in the Management of Graves' Disease: A Friend and Foe
por: Butt, Muhammad I, et al.
Publicado: (2023)

Progressive Thymic Hyperplasia With Graves’ Disease: A Case Report
por: Ogawa, Noriko, et al.
Publicado: (2023)

Hypercalcemia Secondary to Immune Reconstitution Inflammatory Syndrome in an HIV-Infected Individual With Mycobacterium avium Complex
por: Awasty, Sanjana S, et al.
Publicado: (2021)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Successful Management of Patients with Co-existent Graves’ Disease and Autoimmune Hepatitis
por: Rana, Sanah, et al.
Publicado: (2019)

Thyroid-Stimulatory Antibody as a Predictive Factor for Graves’ Disease Relapse
por: Da Silva Santos, Tiago, et al.
Publicado: (2022)

The Clinical Implications of Anti-thyroid Peroxidase Antibodies in Graves’ Disease in Basrah
por: Alhubaish, Emad S, et al.
Publicado: (2023)

Graves’ Disease in a Young Patient With Turner’s Syndrome: The Genetic Association
por: Majumder, Anirban, et al.
Publicado: (2023)

Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah
por: Radhi, Maher A, et al.
Publicado: (2023)

Advancing Preoperative Strategies for Thyroidectomy in Graves’ Disease: A Narrative Review
por: Elkhoury, David, et al.
Publicado: (2023)

Graves' Disease Presenting as Painful Goiter: A Case Report and Review of the Literature
por: Shahbaz, Amir, et al.
Publicado: (2018)

Resistant Thyrotoxicosis due to Graves' Disease in Pregnancy: Case Report and Review of the Literature
por: Linardi, Anastasia, et al.
Publicado: (2018)

Thyroid Storm Presenting as Acute Liver Failure in a Patient with Graves’ Disease
por: Hayat, Muhammad Hashim, et al.
Publicado: (2020)

Selective Attention and Information Processing Speed in Graves’ Disease: Stroop Interference Effect
por: Ekinci, İskender, et al.
Publicado: (2021)

Fluctuating Hyperthyroidism and Hypothyroidism in Graves’ Disease: The Swinging Between Two Clinical Entities
por: Shrestha, Aakriti, et al.
Publicado: (2022)

New-Onset Graves’ Disease With Thyroid Storm After COVID-19 Infection
por: Shermetaro, Angela, et al.
Publicado: (2023)

Atypical Asymmetric Presentation of Severe Graves’ Orbitopathy
por: Gupta, Priyanka, et al.
Publicado: (2023)

Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
por: Reddy, Mithun K, et al.
Publicado: (2020)

New-Onset Graves’ Disease in the Background of Hashimoto’s Thyroiditis: Spectrums of the Same Disease With Changing Autoantibodies
por: Arshad, Iqra, et al.
Publicado: (2022)

Comparison Between the Treatment Modalities for Graves' Disease at King Abdulaziz Medical City, Jeddah
por: Zarif, Hawazen A, et al.
Publicado: (2020)

Thyrotoxic Periodic Paralysis in a Young Hispanic Male With Newly Diagnosed Grave's Disease
por: Mabile, Colten M, et al.
Publicado: (2021)

Graves’ Disease in a Patient With Human Immunodeficiency Virus Infection as an Immune Reconstitution Inflammatory Syndrome
por: Ayad, Sarah, et al.
Publicado: (2021)

Unprovoked Isolated Pulmonary Embolism and Graves’ Disease in a Patient With Dyspnea: A Case Report
por: Bisural, Roshan, et al.
Publicado: (2022)

Rare Presentation of a Common Disease: Graves' Thyrotoxicosis Presented With Non-parathyroid Hypercalcemia and Jaundice
por: Ajwah, Ibrahim, et al.
Publicado: (2023)

An Intriguing Case of Gynecomastia in an Elderly Male as the Initial Presentation of Graves’ Disease: A Case Report
por: Sravya, S.L., et al.
Publicado: (2023)

Influence of Thyroid Peroxidase Antibodies Serum Levels in Graves' Disease: A Retrospective Cohort Study
por: Guia Lopes, Maria L, et al.
Publicado: (2023)

Atezolizumab-Induced Hypothyroidism in a Patient With Pre-existing Triiodothyronine (T3) Thyrotoxicosis Due to Graves’ Disease: A Case Report and Literature Review
por: Oyibo, Samson O, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vhhhu8lcqca3b0u6o20294opb